Cytarabine
- Product NDC
- 67457-454
- 11-digit product format
- 674570454
- Labeler code
- 67457
- Product ID
- 67457-454_2bef8f94-a567-49fc-b025-04e7c71b9268
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cytarabine
- Dosage form
- INJECTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA200914
- Marketing category
- ANDA
- Marketing start
- 2011-12-14
- Marketing end
- 2021-12-31
- Substance
- CYTARABINE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-454-50 | 67457045450 | 1 VIAL in 1 CARTON (67457-454-50) > 50 mL in 1 VIAL | 1 vial | 2011-12-14 | 2021-12-31 | No | No | Current |